Velocity Bio, Inc.
- Biotech or pharma, therapeutic R&D
Velocity Bio is a venture-backed spinout from Stanford University developing microfluidic technologies to discover small molecule therapies for classically "undruggable"targets. Velocity's platforms enable quantitative biochemical assays of enzyme function and small-molecule binding with microfluidic devices capable of parallelizing classical assays by 1,000-fold while reducing reagent needed by 10,000-fold.